KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthpeak Properties (DOC) EBITDA (2016 - 2025)

Historic EBITDA for Healthpeak Properties (DOC) over the last 17 years, with Q4 2025 value amounting to $205.8 million.

  • Healthpeak Properties' EBITDA rose 18324.1% to $205.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$479.8 million, marking a year-over-year increase of 5385.43%. This contributed to the annual value of $592.5 million for FY2025, which is 15709.29% up from last year.
  • According to the latest figures from Q4 2025, Healthpeak Properties' EBITDA is $205.8 million, which was up 18324.1% from -$239.3 million recorded in Q3 2025.
  • In the past 5 years, Healthpeak Properties' EBITDA ranged from a high of $205.8 million in Q4 2025 and a low of -$303.0 million during Q1 2024
  • For the 5-year period, Healthpeak Properties' EBITDA averaged around -$175.4 million, with its median value being -$173.3 million (2023).
  • As far as peak fluctuations go, Healthpeak Properties' EBITDA crashed by 7570.88% in 2024, and later surged by 18324.1% in 2025.
  • Healthpeak Properties' EBITDA (Quarter) stood at -$175.1 million in 2021, then fell by 19.63% to -$209.5 million in 2022, then rose by 20.28% to -$167.0 million in 2023, then plummeted by 48.0% to -$247.2 million in 2024, then soared by 183.24% to $205.8 million in 2025.
  • Its EBITDA was $205.8 million in Q4 2025, compared to -$239.3 million in Q3 2025 and -$233.5 million in Q2 2025.